Estrogen conjugation and antibody binding interactions in surface plasmon resonance biosensing

Steroids

Volumn 71, Issue 7, 2006, Pages 618-631

  Mitchell, John S ^a,b   Wu, Yinqiu ^a   Cook, Christian J ^a   Main, Lyndsay ^b  

^a THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^b UNIVERSITY OF WAIKATO   (New Zealand)

Author keywords

17 Estradiol; Anti estradiol mAb; Immunoassay; Surface plasmon resonance

Indexed keywords

3 MERCAPTOPROPIONIC ACID; CARBOXYLIC ACID; CARBOXYMETHYLDEXTRAN; CONJUGATED ESTROGEN; ESTRADIOL; ESTRONE; GOLD; MACROGOL; MONOCLONAL ANTIBODY; STEROID; SULFIDE;

ANTIGEN BINDING; ARTICLE; BIOSENSOR; GENETIC PROCEDURES; MANNICH REACTION; PROTEIN BINDING; REFRACTION INDEX; SUBSTITUTION REACTION; SURFACE PLASMON RESONANCE; SYNTHESIS;

ANTIBODIES; ESTRADIOL; ESTRONE; ETHYLENE GLYCOL; IMMUNOASSAY; SURFACE PLASMON RESONANCE;

EID: 33646857238     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2006.03.004     Document Type: Article

References (35)

1. Homola J. Present and future of surface plasmon resonance biosensors. Anal Bioanal Chem 377 (2003) 528-539
2. Adamczyk M., Chen Y., Grote J., and Mattingly P.G. O-(Fluoresceinylmethyl)hydroxylamine (OFMHA): a reagent for the preparation of fluoresecent O-(fluoresceinylmethyl)oxime (FMO)-steroid conjugates. Steroids 64 (1999) 283-290
3. Adamczyk M., Grote J., Mattingly P.G., and Pan Y. O-(Acridinium)hydroxylamine (AHA): a reagent for the preparation of chemiluminescent acridinium oxime (AO)-steroid conjugates. Steroids 65 (2000) 387-394
4. 125I radiolabels. J Steroid Biochem 19 (1983) 1363-1370
5. Tanaka T., Suguro N., Shiratori Y., and Kubodera A. Specific antisera for the radioimmunoassay of estradiol-3-sulfate. J Steroid Biochem 22 (1985) 285-288
6. Miller C.P., Jirkovsky I., Tran B.D., Harris H.A., Moran R.A., and Komm B.S. Synthesis and estrogenic activities of novel 7-thiosubstituted estratriene derivatives. Bioorg Med Chem Lett 10 (2000) 147-151
7. Lindner H.R., Perel E., Friedlander A., and Zeitlin A. Specificity of antibodies to ovarian hormones in relation to the site of attachment of the steroid hapten to the peptide carrier. Steroids 19 (1972) 357-375
8. Rao P.N., Wang Z., Cessac J., and Moore P.H. Synthesis of new immunogens for estrone and estradiol-17β and antisera evaluation. Steroids 63 (1998) 141-145
9. Meltola N., Jauria P., Saviranta P., and Mikola H. Synthesis of novel europium-labeled estradiol derivatives for time-resolved fluoroimmunoassays. Bioconjugate Chem 10 (1999) 325-331
10. Ghaffari M.A., and Abul-Hajj Y.J. Reaction of thiol nucleophiles with 1,2-epoxy- and 4 5-epoxy-estrene-3-one-17β-ols. J. Steroid Biochem 37 (1990) 237-244
11. Jellinck P.H., Lewis J., and Boston F. Further evidence for the formation of an estrogen-peptide conjugate by rat liver in vitro. Steroids 10 (1967) 329-346
12. Abul-Hajj Y., and Cisek P.L. Regioselective reaction of thiols with catechol estrogens and estrogen-o-quinones. J Steroid Biochem 25 (1986) 245-247
13. Cao K., Stack D.E., Ramanathan R., Gross M.L., Rogan E.G., and Cavalieri E.L. Synthesis and structure elucidation of estrogen quinines conjugated with cysteine, N-acetylcysteine, and glutathione. Chem Res Toxicol 11 (1998) 909-916
14. Hosoda H., Sakai Y., Yoshida H., Miyairi S., Ishii K., and Nambara T. The preparation of steroid n-hydroxysuccinimide esters and their reactivities with bovine serum albumin. Chem Pharm Bull 27 (1979) 742-746
15. Hosoda H., Miyairi S., Kobayashi N., and Nambara T. Specificity of antisera raised against cortisol-4-bovine serum albumin conjugates in radioimmunoassay. Chem Pharm Bull 28 (1980) 3369-3374
16. 4-3-ketosteroids. Chem Pharm Bull 30 (1982) 202-205
17. Wu Y., Mitchell J.S., Cook C.J., and Main L. Evaluation of progesterone-ovalbumin conjugates with different length linkers in enzyme-linked immunosorbent assay and surface plasmon resonance-based immunoassay. Steroids 67 (2002) 565-572
18. Mitchell J.S., Wu Y., Cook C.J., and Main L. Sensitivity enhancement of surface plasmon resonance biosensing of small molecules. Anal Biochem 343 (2005) 125-135
19. Otsuka H., Nagasaki Y., and Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev 55 (2003) 403-419
20. Kurusu F., Ohno H., Kaneko M., Nagasaki Y., and Kataoka K. Functionalization of gold electrode surface with heterobifunctional poly(ethylene oxide)s having both mercapto and aldehyde groups. Polym Adv Technol 14 (2003) 27-34
21. Usami M., Mitsunaga K., and Ohno Y. Estrogen receptor binding assay of chemicals with a surface plasmon resonance biosensor. J Steroid Biochem Mol Biol 81 (2002) 47-55
22. Rich R.L., Hoth L.R., Geoghegan K.F., Brown T.A., LeMotte P.K., Simons S.P., et al. Kinetic analysis of estrogen receptor/ligand interactions. Proc Natl Acad Sci 99 (2002) 8562-8567
23. Adamczyk M., Chen Y.Y., Gebler J.C., Johnson D.D., Mattingly P.G., Moore J.A., et al. Evaluation of chemiluminescent estradiol conjugates by using surface plasmon resonance detector. Steroids 65 (2000) 295-303
24. Lovely C.J., Bhat A.S., Coughenour H.D., Gilbert N.E., and Bruggemeier R.W. Synthesis and biological evaluation of 4-(hydroxyalkyl)estradiols and related compounds. J Med Chem 40 (1997) 3756-3764
25. Slaunwhite W.R., and Neely L. Bromination of phenolic steroids. I. Substitution of estrone and 17β-estradiol in ring A. J Org Chem 27 (1962) 1749-1752
26. Schwenk E., Castle C.G., and Joachim E. Halogenation of estrone and derivatives. J Org Chem 28 (1963) 136-144
27. Wilbur D.S., Hamlin D.K., Buhler K.R., Pathare P.M., Vessella R.L., Stayton P.S., et al. Streptavidin in antibody pretargeting. 2. Evaluation of methods for decreasing localization of streptavidin to kidney while retaining its tumour-binding capacity. Bioconjugate Chem 9 (1998) 322-330
28. Exley D., and Woodhams B. The specificity of antisera raised by oestradiol-17β-3-hemisuccinyl-bovine serum albumin. Steroids 27 (1976) 813-820
29. Page P.C.B., Hussain F., Bonham N.M., Morgan P., Maggs J.L., and Park B.K. Regioselective synthesis of A-ring halogenated derivatives of 17α-ethynyloestradiol. Tetrahedron 47 (1991) 2871-2878
30. Numazawa M., Kimura K., Ogata M., and Nagaoka M. Reductive dehalogenation of 2,4-dihalogeno estrogens having a 3-hydroxy substituent by formic acid, potassium iodide, or ascorbic acid. J Org Chem 50 (1985) 5421-5423
31. Hermanson G.T. Bioconjugate techniques (1996), Academic Press, San Diego p. 449-53
32. Hatzidakis G., Stefanakis A., and Krambovitis E. Comparison of different antibody-conjugate derivatives for the development of a sensitive and specific progesterone assay. J Reprod Fertil 97 (1993) 557-561
33. Munro C.J., Stabenfeldt G.H., Cragun J.R., Addiego L.A., Overstreet J.W., and Lasley B.L. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem 37 (1991) 838-844
34. Draisci R., Volpe G., Compagnone D., Purificato I., delli Quadri F., and Palleschi G. Development of an electrochemical ELISA for the screening of 17 beta-estradiol and application to bovine serum. Analyst 125 (2000) 1419-1423
35. Miyashita M., Shimada T., Hisashi M., and Akamatsu M. Surface plasmon resonance-based immunoassay for 17beta-estradiol and its application to the measurement of estrogen receptor-binding activity. Anal Bioanal Chem 381 (2005) 667-673